Suppr超能文献

使用毛蕊异黄酮和丹参酮共载的线粒体靶向脂质-聚合物杂化纳米系统治疗急性心肌梗死:制备、表征及抗心肌梗死活性评估

Acute myocardial infarction therapy using calycosin and tanshinone co-loaded mitochondria targeted lipid-polymer hybrid nano-system: Preparation, characterization, and anti myocardial infarction activity assessment.

作者信息

Yan Jieke, Guo Jing, Wang Yuzhen, Xing Xiaowei, Zhang Xuguang, Zhang Guanghao, Dong Zhaoqiang

机构信息

Department of Renal Transplantation, The Second Hospital of Shandong University, Ji'nan, 250033 Shandong Province, PR China.

Department of Gynaecology, The Second Hospital of Shandong University, Ji'nan, 250033 Shandong Province, PR China.

出版信息

Biomed Pharmacother. 2022 Nov;155:113650. doi: 10.1016/j.biopha.2022.113650. Epub 2022 Sep 19.

Abstract

BACKGROUND

Acute myocardial infarction (AMI) is one of the most common ischemic heart diseases. However, lack of sufficient drug concentrations in the ischemic heart may led to treatment failure. It is urgent for researchers to engineer novel drug delivery systems to enhance the targeted delivery of cardioprotective agents.

OBJECTIVE

The aim of the present study was to investigate the anti-AMI ability of calycosin (CAL) and tanshinone (TAN) co-loaded mitochondria targeted lipid-polymer hybrid nano-system.

METHODS

CAL and TAN combined lipid-polymer hybrid nano-systems were prepared and MTP-131 was conjugated with PEG and modified onto the nanoparticles to achieve MTP-CAL/TAN NS. The physicochemical properties of nano-systems were characterized, the AMI therapy ability of the systems was investigated in AMI rats' model.

RESULTS

The size of MTP-CAL/TAN NS was 168.7 ± 5.1 nm, with a surface charge of - 21.3 ± 2.3 mV. The area under the curve (AUC) and blood circulation half-life (T) of MTP-CAL/TAN NS was 178.86 ± 6.62 μg·min/mL and 0.47 h, respectively. MTP-CAL/TAN NS exhibited the most significant infarct size reduction effect of 23.9 %.

CONCLUSION

MTP-CAL/TAN NS exhibited the highest heart accumulation and best infarct size reduction effect, which could be used as a promising system for efficient treatment of cardiovascular diseases.

摘要

背景

急性心肌梗死(AMI)是最常见的缺血性心脏病之一。然而,缺血心脏中药物浓度不足可能导致治疗失败。研究人员迫切需要设计新型药物递送系统,以增强心脏保护剂的靶向递送。

目的

本研究旨在探讨载有毛蕊异黄酮(CAL)和丹参酮(TAN)的线粒体靶向脂质-聚合物杂化纳米系统抗急性心肌梗死的能力。

方法

制备CAL和TAN联合脂质-聚合物杂化纳米系统,并将线粒体靶向肽-131(MTP-131)与聚乙二醇(PEG)偶联并修饰到纳米颗粒上,以制备MTP-CAL/TAN纳米系统(NS)。对纳米系统的理化性质进行表征,并在急性心肌梗死大鼠模型中研究该系统的急性心肌梗死治疗能力。

结果

MTP-CAL/TAN NS的粒径为168.7±5.1nm,表面电荷为-21.3±2.3mV。MTP-CAL/TAN NS的曲线下面积(AUC)和血液循环半衰期(T)分别为178.86±6.62μg·min/mL和0.47h。MTP-CAL/TAN NS表现出最显著的梗死面积缩小效果,缩小了23.9%。

结论

MTP-CAL/TAN NS表现出最高的心脏蓄积和最佳的梗死面积缩小效果,可作为一种有前景的高效治疗心血管疾病的系统。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验